Benjamin Brakel

Benjamin Brakel Email and Phone Number

Medical Student in Glioblastoma Stem Cell Research Program @ Centre for Discovery in Cancer Research (CDCR) - McMaster University
Benjamin Brakel's Location
Vancouver, British Columbia, Canada, Canada
About Benjamin Brakel

Working at the intersect of functional genomics and immunotherapeutics to uncover and target novel vulnerabilities of brain cancer stem cells, while driving clinical advances in neurosurgical techniques.

Benjamin Brakel's Current Company Details
Centre for Discovery in Cancer Research (CDCR) - McMaster University

Centre For Discovery In Cancer Research (Cdcr) - Mcmaster University

View
Medical Student in Glioblastoma Stem Cell Research Program
Benjamin Brakel Work Experience Details
  • Centre For Discovery In Cancer Research (Cdcr) - Mcmaster University
    Glioblastoma Stem Cell Research, Dr. Sheila Singh Laboratory
    Centre For Discovery In Cancer Research (Cdcr) - Mcmaster University Jan 2021 - Present
    Hamilton, Ontario, Canada
    Co-Second Author, Nature Medicine: Through integrative genomic analyses and genome-wide genetic perturbation screens, we identified a PTP4A2-ROBO1 axonal guidance signaling axis as a modulator of glioblastoma stem cell migration and tumorgenicity. Targeting this dependency using ROBO1 CAR T cells doubled median survival in patient-derived xenograft models of GBM, and irradicated 50-100% of tumours in brain metastasis and medulloblastoma xenografted mice.First Author, In Progress: Through integrating genome-wide genetic perturbation and chemoradiotherapy-sensitizing screens, we identified FEN1 as a functional driver of both glioblastoma stem cell proliferation and temozolomide resistance. Genetic knockdown of FEN1 significantly increased survival of patient-derived xenograft models of GBM, and FEN1 inhibition has shown marked synergy with temozolomide. Subsequent bulk and single cell RNA sequencing analyses have connected FEN1 dependency to cell stemness. These findings helped support a >$1M CIHR Project Grant for the development of FEN1 inhibitors.
  • Bc Children'S Hospital Research Institute
    Neurosurgery Research (Clinical) - Dr. Faizal Haji
    Bc Children'S Hospital Research Institute May 2024 - Present
    Vancouver, British Columbia, Canada
    First Author, In Progress: Through conducting a large longitudinal cohort study, we have shown that the addition of barrel stave osteotomy to endoscopic suturectomy for craniosynostosis improves long-term cephalometric outcomes while having no significant effect on operative burden.
  • Vancouver General Hospital
    Stroke Research (Clinical) - Dr. Thalia Field
    Vancouver General Hospital Dec 2023 - Present
    Vancouver, British Columbia, Canada
    First Author, In Progress: Conducting large-scale international survey on practice patterns and perspectives on endovascular therapy for the treatment of cerebral venous thrombosis. With 861 respondents across 61 countries, we have developed a comprehensive characterization of indications, techniques, and long-term management for endovascular treatment of CVT, with geographic resolution uncovering significant heterogeneity in practices across the world.
  • Vancouver General Hospital
    Neurosurgery Research (Clinical) - Dr. Serge Makarenko
    Vancouver General Hospital Apr 2023 - Present
    Vancouver, British Columbia, Canada
    First Author, Journal of Neurological Surgery Part B, Skull Base: Proof of concept of a novel technique using jugular bulb pressure to optimize head positioning prior to vestibular schwannoma resection, demonstrating reduced intracranial pressure during surgery.First Author, In Progress: Conducting longitudinal survey of return to work function in patients following craniotomy for various neurosurgical conditions.
  • The Hospital For Sick Children
    Hemophilia Diagnostics Research, Dr. Andrea Doria Laboratory
    The Hospital For Sick Children Apr 2019 - Dec 2022
    Toronto, Ontario, Canada
    First Author, Research and Practice in Thrombosis and Haemostasis: Identified MRI T2 mapping as a promising tool for detecting early biochemical cartilage damage in pediatric hemophilic arthropathy, before it's visible with standard radiographic methods. Validated as an early diagnostic tool before irreversible damage occurs.
  • Michael G. Degroote Institute For Infectious Disease Research
    Computational Covid-19 Research, Dr. Jakob Magolan Laboratory
    Michael G. Degroote Institute For Infectious Disease Research Apr 2020 - Sep 2020
    Hamilton, Ontario, Canada
    Biocomputational design of small molecule therapeutics for SARS-CoV-2 preceding the synthesis and biochemical evaluation of these compounds in experimental assays. Developed compounds with high binding affinity, synthetic tractability, and drug-like properties.

Benjamin Brakel Education Details

Frequently Asked Questions about Benjamin Brakel

What company does Benjamin Brakel work for?

Benjamin Brakel works for Centre For Discovery In Cancer Research (Cdcr) - Mcmaster University

What is Benjamin Brakel's role at the current company?

Benjamin Brakel's current role is Medical Student in Glioblastoma Stem Cell Research Program.

What schools did Benjamin Brakel attend?

Benjamin Brakel attended The University Of British Columbia, Mcmaster University.

Not the Benjamin Brakel you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.